12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | November 09, 2022 02:44pm

Gainers

• Merrimack Pharmaceuticals (NASDAQ:MACK) shares increased by 195.8% to $11.83 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 28.1 million, which is 113716.7% of its average full-day volume over the last 100 days. The company's market cap stands at $158.6 million. As per the press release, Q3 earnings came out 4 days ago.
• NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock moved upwards by 42.4% to $1.78. As of 12:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 33.4 million, which is 3695.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 million.
• OptimizeRx (NASDAQ:OPRX) stock moved upwards by 28.85% to $18.71. The current volume of 319.8K shares is 124.1% of OptimizeRx's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $337.2 million. The company's, Q3 earnings came out yesterday.
• Kala Pharmaceuticals (NASDAQ:KALA) stock increased by 27.76% to $6.67. Kala Pharmaceuticals's stock is trading at a volume of 7.1 million shares as of 12:30 EST. This is 23646.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million. As per the news, the Q3 earnings report came out yesterday.
• Histogen (NASDAQ:HSTO) stock moved upwards by 24.57% to $1.24. As of 12:30 EST, Histogen's stock is trading at a volume of 6.1 million, which is 1297.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.0 million.
• Health Catalyst (NASDAQ:HCAT) stock rose 23.8% to $8.01. As of 12:30 EST, Health Catalyst's stock is trading at a volume of 1.8 million, which is 173.5% of its average full-day volume over the last 100 days. The company's market cap stands at $438.3 million. As per the press release, Q3 earnings came out yesterday.

Losers

• Clovis Oncology (NASDAQ:CLVS) stock fell 74.2% to $0.25 during Wednesday's regular session. Clovis Oncology's stock is trading at a volume of 33.3 million shares as of 12:30 EST. This is 1118.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $36.5 million. As per the news, the Q3 earnings report came out today.
• Athersys (NASDAQ:ATHX) shares fell 54.89% to $0.58. The current volume of 6.3 million shares is 447.0% of Athersys's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $7.0 million.
• Trevena (NASDAQ:TRVN) shares fell 31.32% to $0.12. As of 12:30 EST, Trevena's stock is trading at a volume of 2.5 million, which is 371.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.0 million. As per the press release, Q3 earnings came out today.
• Emergent BioSolutions (NYSE:EBS) stock decreased by 29.35% to $13.94. Trading volume for Emergent BioSolutions's stock is 2.0 million as of 12:30 EST. This is 331.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $695.0 million. The company's, Q3 earnings came out yesterday.
• Baudax Bio (NASDAQ:BXRX) stock declined by 23.75% to $0.14. Baudax Bio's stock is trading at a volume of 1.3 million shares as of 12:30 EST. This is 71.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.7 million. As per the press release, Q3 earnings came out yesterday.
• Revelation Biosciences (NASDAQ:REVBU) shares fell 20.93% to $0.27. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATHX BXRX CLVS EBS HCAT HSTO KALA MACK NRBO OPRX REVBU TRVN